Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Rusfertide acetate by Protagonist Therapeutics for Polycythemia Vera: Likelihood of Approval
Rusfertide acetate is under clinical development by Protagonist Therapeutics and currently in Phase III for Polycythemia Vera. According to GlobalData,...